Martin Price

Views & Analysis

The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.

News

The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.